Opthea (OPT) Projected to Post Quarterly Earnings on Friday

Opthea (NASDAQ:OPT) will likely be announcing its H2 2025 results before the market opens on Friday, September 5th. Analysts expect Opthea to post earnings of ($0.0456) per share and revenue of $0.0650 million for the quarter. Interested persons can check the company’s upcoming H2 2025 earningsummary page for the latest details on the call scheduled for Thursday, September 11, 2025 at 8:00 PM ET.

Opthea Stock Up 7.2%

Shares of NASDAQ OPT opened at $3.41 on Wednesday. Opthea has a 52 week low of $1.79 and a 52 week high of $6.30. The firm’s fifty day moving average is $3.41 and its 200 day moving average is $3.52.

About Opthea

Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.